American Society of Clinical Oncology

SHERPA: White

People

  1. Horwitz
    Horwitz
  2. Zelenetz
    Zelenetz
  3. Hamlin
    Hamlin
  4. Palomba
    Palomba
  5. Bernal
    Bernal
  6. Byrne
    Byrne
  7. Curran
    Curran
  8. Drullinsky
    Drullinsky
  9. Dunphy
    Dunphy
  10. Giralt
    Giralt

Groups

  1. Center for Hematologic Malignancies (21)
  2. Department of Medicine (21)
  3. Hematologic Malignancies, Division of (21)
  4. Lymphoma (21)
  5. Population Sciences Research Program (9)
  6. Executive Committee, Center for Hematologic Malignancies (4)
  7. Survivorship Research (4)
  8. Dermatology (3)
  9. Division of Subspecialty Medicine (3)
  10. Dermatology Service (2)
Search Within
  1. "2015"
  2. "Lymphoma"
Formats
  1. Meeting Abstract (14)
  2. Journal Article (7)
Groups
  1. Center for Hematologic Malignancies (21)
  2. Department of Medicine (21)
  3. Hematologic Malignancies, Division of (21)
  4. Lymphoma (21)
  5. Population Sciences Research Program (9)
  6. Executive Committee, Center for Hematologic Malignancies (4)

More Groups

People
  1. Steven Horwitz (9)
  2. Andrew Zelenetz (7)
  3. Anas Younes (4)
  4. John Gerecitano (4)
  5. Craig Moskowitz (3)
  6. Maria Palomba (3)

More People

Years
  1. 2015 (21)
Publications
  1. Journal of Clinical Oncology (21)

Results (21)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic significance of diffuse large B-cell lymphoma cell of origin: Seeing the forest and the trees
    Journal Article

    Younes, A.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II investigator-initiated study of brentuximab vedotin in mycosis fungoides and Sézary syndrome with variable CD30 expression level: A multi-institution collaborative project
    Journal Article

    Kim, Y. H.; Tavallaee, M.; Sundram, U.; Salva, K. A.; Wood, G. S.; Li, S. F.; Rozati, S.; Nagpal, S.; Krathen, M.; Reddy, S.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Randomized phase II trial comparing obinutuzumab (GA101) with rituximab in patients with relapsed CD20(+) indolent B-cell non-Hodgkin lymphoma: Final analysis of the GAUSS study
    Journal Article

    Sehn, L. H.; Goy, A.; Offner, F. C.; Martinelli, G.; Caballero, M. D.; Gadeberg, O.; Baetz, T.; Zelenetz, A. D.; Gaidano, G.; Fayad, L. E.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and Sézary syndrome: Effect of specific prognostic markers on survival and development of a prognostic model
    Journal Article

    Scarisbrick, J. J.; Prince, H. M.; Vermeer, M. H.; Quaglino, P.; Horwitz, S.; Porcu, P.; Stadler, R.; Wood, G. S.; Beylot-Barry, M.; Pham-Ledard, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Early relapse of follicular lymphoma after rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone defines patients at high risk for death: An analysis from the National LymphoCare Study
    Journal Article

    Casulo, C.; Byrtek, M.; Dawson, K. L.; Zhou, X.; Farber, C. M.; Flowers, C. R.; Hainsworth, J. D.; Maurer, M. J.; Cerhan, J. R.; Link, B. K.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Belinostat in patients with relapsed or refractory peripheral T-cell lymphoma: Results of the pivotal phase II BELIEF (CLN-19) study
    Journal Article

    O'Connor, O. A.; Horwitz, S.; Masszi, T.; Van Hoof, A.; Brown, P.; Doorduijn, J.; Hess, G.; Jurczak, W.; Knoblauch, P.; Chawla, S.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II intergroup trial of alisertib in relapsed and refractory peripheral T-cell lymphoma and transformed Mycosis fungoides: SWOG 1108
    Journal Article

    Barr, P. M.; Li, H.; Spier, C.; Mahadevan, D.; LeBlanc, M.; Ul Haq, M.; Huber, B. D.; Flowers, C. R.; Wagner-Johnston, N. D.; Horwitz, S. M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I trial of 19-28z chimeric antigen receptor modified T cells (19-28z CAR-T) post-high dose therapy and autologous stem cell transplant (HDT-ASCT) for relapsed and refractory (rel/ref) aggressive B-cell non-Hodgkin lymphoma (B-NHL)
    Meeting Abstract

    Sauter, C. S.; Riviere, I.; Bernal, Y.; Wang, X. Y.; Purdon, T.; Yoo, S.; Moskowitz, C. H.; Giralt, S.; Matasar, M. J.; Curran, K. J.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Effect of prednisone and rituximab prephase on early toxicity in older DLBCL patients (pts) receiving RCHOP within a NHL specific comprehensive geriatric assessment (CGA) trial
    Meeting Abstract

    Owens, C. N.; Iannotta, A.; Gerecitano, J. F.; Matasar, M. J.; Noy, A.; Moskowitz, C. H.; Drullinsky, P.; Palomba, M. L.; Straus, D. J.; Horwitz, S. M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase I/II trial of the combination of romidepsin and lenalidomide in patients with relapsed/refractory lymphoma and myeloma: Activity in T-cell lymphoma
    Meeting Abstract

    Mehta-Shah, N; Lunning, M. A.; Boruchov, A. M.; Ruan, J.; Nair, S.; Lynch, P.; Byrne, R.; Moskowitz, A. J.; Matasar, M. J.; Gerecitano, J. F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save